Switch theme
Sign up to access all valuation multiples
Peptron Inc is a biotechnology company engaged in developing fundamental technologies for peptide-based medicines. Its technology includes PeptrEX and SmartDepot. PeptrEX is an automatic system, enabling to synthesize simultaneously from a few to hundred types of peptides. SmartDepot is a proprietary ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of the drug. The group’s research and development products include Luphere Depot for the treatment of prostate cancer and endometriosis, SR Exenatide PT302 AND SR EXENATIDE PT304 for the treatment of type II diabetes, SR Exenatide PT320 and 330 for the treatment of Parkinson’s and Alzheimer’s disease and SR Octreotide for the treatment of acromegaly and carcinoid tumor.
1997
n/a
LTM Revenue n/a
LTM EBITDA n/a
$2.6B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Peptron has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Peptron achieved revenue of $2.1M and an EBITDA of -$12.6M.
Peptron expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Peptron valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $2.3M | $2.1M | XXX | XXX | XXX |
| Gross Profit | $2.3M | $0.8M | XXX | XXX | XXX |
| Gross Margin | 99% | 36% | XXX | XXX | XXX |
| EBITDA | -$8.6M | -$12.6M | XXX | XXX | XXX |
| EBITDA Margin | -379% | -585% | XXX | XXX | XXX |
| Net Profit | -$10.3M | -$10.8M | XXX | XXX | XXX |
| Net Margin | -451% | -505% | XXX | XXX | XXX |
| Net Debt | $2.7M | $3.3M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Peptron's stock price is KRW 168300 (or $115).
Peptron has current market cap of KRW 3.91T (or $2.7B), and EV of KRW 3.79T (or $2.6B).
See Peptron trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.6B | $2.7B | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Peptron has market cap of $2.7B and EV of $2.6B.
Peptron's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Peptron's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Peptron and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $2.6B | XXX | XXX | XXX |
| EV/Revenue | 1203.6x | XXX | XXX | XXX |
| EV/EBITDA | -205.6x | XXX | XXX | XXX |
| P/E | -177.4x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -254.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpPeptron's NTM/LTM revenue growth is n/a
Peptron's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, Peptron's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Peptron's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Peptron and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -6% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -585% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 46% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 37% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 54% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 385% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 559% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Armata Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Peptron acquired XXX companies to date.
Last acquisition by Peptron was XXXXXXXX, XXXXX XXXXX XXXXXX . Peptron acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Peptron founded? | Peptron was founded in 1997. |
| Where is Peptron headquartered? | Peptron is headquartered in South Korea. |
| Who is the CEO of Peptron? | Peptron's CEO is Mr. Ho-Il Choi. |
| Is Peptron publicy listed? | Yes, Peptron is a public company listed on KRX. |
| What is the stock symbol of Peptron? | Peptron trades under 087010 ticker. |
| When did Peptron go public? | Peptron went public in 2015. |
| Who are competitors of Peptron? | Similar companies to Peptron include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics. |
| What is the current market cap of Peptron? | Peptron's current market cap is $2.7B |
| What is the current revenue growth of Peptron? | Peptron revenue growth between 2023 and 2024 was -6%. |
| Is Peptron profitable? | Yes, Peptron is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
